Please provide your email address to receive an email when new articles are posted on . “Despite the common clinical practice of delaying feedings after [percutaneous endoscopic gastrostomy (PEG)] ...
The Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for Tiglutik (riluzole; ITF Pharma) oral suspension to include administration via percutaneous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback